AstraZeneca’s China president under ‘ongoing investigation’, company says

AstraZeneca’s China president is under investigation in mainland China, the drug company said on Wednesday.

Leon Wang was described as cooperating “with an ongoing investigation”, the pharmaceutical and biotechnology company said in a statement.

“Our China operations continue under the leadership of the current general manager of AstraZeneca China,” the British-Swedish company added.

The company has yet to elaborate whether Wang is in custody, nor have his whereabouts been disclosed.

AstraZeneca China said it would “fully cooperate with the investigation”.

According to his LinkedIn page, Wang joined AstraZeneca in 2013 and became the company’s country president in 2014. He has served as an executive vice-president responsible for commercial operations in China since 2017.